NVO
Income statement / Annual
Last year (2023), Novo Nordisk A/S's total revenue was $232.26 B,
an increase of 31.26% from the previous year.
In 2023, Novo Nordisk A/S's net income was $83.68 B.
See Novo Nordisk A/S’s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
FY-2014
|
| Period Ended |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
12/31/2015 |
12/31/2014 |
| Operating Revenue |
$232.26 B
|
$176.95 B
|
$140.80 B
|
$126.95 B
|
$122.02 B
|
$111.83 B
|
$111.70 B
|
$111.78 B
|
$107.93 B
|
$88.81 B
|
| Cost of Revenue |
$35.77 B |
$28.45 B |
$23.66 B |
$20.93 B |
$20.09 B |
$17.62 B |
$17.63 B |
$17.18 B |
$16.19 B |
$14.56 B |
| Gross Profit |
$196.50 B |
$148.51 B |
$117.14 B |
$106.01 B |
$101.93 B |
$94.21 B |
$94.06 B |
$94.60 B |
$91.74 B |
$74.24 B |
| Gross Profit Ratio |
0.85 |
0.84 |
0.83 |
0.84 |
0.84 |
0.84 |
0.84 |
0.85 |
0.85 |
0.84 |
| Research and Development
Expenses |
$32.44 B
|
$24.05 B
|
$17.77 B
|
$15.46 B
|
$14.22 B
|
$14.81 B
|
$14.01 B
|
$14.56 B
|
$13.61 B
|
$13.76 B
|
| General & Administrative
Expenses |
$4.86 B
|
$4.47 B
|
$4.05 B
|
$3.96 B
|
$4.01 B
|
$3.92 B
|
$3.78 B
|
$3.96 B
|
$3.86 B
|
$3.54 B
|
| Selling & Marketing
Expenses |
$56.74 B
|
$46.22 B
|
$37.01 B
|
$32.93 B
|
$31.82 B
|
$29.40 B
|
$28.34 B
|
$28.38 B
|
$28.31 B
|
$23.22 B
|
| Selling, General &
Administrative Expenses |
$61.60 B
|
$50.68 B
|
$41.06 B
|
$36.89 B
|
$35.83 B
|
$33.31 B
|
$32.12 B
|
$32.34 B
|
$32.17 B
|
$26.76 B
|
| Other Expenses |
-$119.00 M |
-$1.03 B |
-$332.00 M |
-$460.00 M |
-$600.00 M |
-$1.15 B |
-$1.04 B |
-$737.00 M |
-$3.48 B |
-$770.00 M |
| Operating Expenses |
$93.92 B |
$73.70 B |
$58.50 B |
$51.89 B |
$49.45 B |
$46.97 B |
$45.10 B |
$46.17 B |
$42.30 B |
$39.75 B |
| Cost And Expenses |
$129.69 B |
$102.15 B |
$82.16 B |
$72.82 B |
$69.54 B |
$64.58 B |
$62.73 B |
$63.35 B |
$58.48 B |
$54.31 B |
| Interest Income |
$1.07 B |
$239.00 M |
$2.89 B |
$337.00 M |
$65.00 M |
$51.00 M |
$69.00 M |
$52.00 M |
$85.00 M |
$167.00 M |
| Interest Expense |
$542.00 M |
$378.00 M |
$2.45 B |
$390.00 M |
$220.00 M |
$85.00 M |
$90.00 M |
$65.00 M |
$6.05 B |
$563.00 M |
| Depreciation &
Amortization |
$9.41 B
|
$6.60 B
|
$5.31 B
|
$5.28 B
|
$4.68 B
|
$3.81 B
|
$2.87 B
|
$2.65 B
|
$2.96 B
|
$3.44 B
|
| EBITDA |
$114.63 B
|
$82.04 B
|
$65.39 B
|
$59.27 B
|
$57.79 B
|
$51.17 B
|
$52.15 B
|
$51.63 B
|
$49.58 B
|
$37.93 B
|
| EBITDA Ratio |
0.49 |
0.46 |
0.48 |
0.47 |
0.47 |
0.46 |
0.47 |
0.46 |
0.49 |
0.43 |
| Operating Income Ratio
|
0.44
|
0.42
|
0.42
|
0.43
|
0.43
|
0.42
|
0.44
|
0.43
|
0.46
|
0.39
|
| Total Other
Income/Expenses Net |
$2.10 B
|
-$5.75 B
|
$436.00 M
|
-$996.00 M
|
-$3.93 B
|
$367.00 M
|
-$287.00 M
|
-$634.00 M
|
-$5.96 B
|
-$396.00 M
|
| Income Before Tax |
$104.67 B |
$69.06 B |
$59.08 B |
$53.13 B |
$48.55 B |
$47.62 B |
$48.68 B |
$47.80 B |
$43.48 B |
$34.10 B |
| Income Before Tax Ratio
|
0.45
|
0.39
|
0.42
|
0.42
|
0.4
|
0.43
|
0.44
|
0.43
|
0.4
|
0.38
|
| Income Tax Expense |
$20.99 B |
$13.54 B |
$11.32 B |
$10.99 B |
$9.60 B |
$8.99 B |
$10.55 B |
$9.87 B |
$8.62 B |
$7.62 B |
| Net Income |
$83.68 B |
$55.53 B |
$47.76 B |
$42.14 B |
$38.95 B |
$38.63 B |
$38.13 B |
$37.93 B |
$34.86 B |
$26.48 B |
| Net Income Ratio |
0.36 |
0.31 |
0.34 |
0.33 |
0.32 |
0.35 |
0.34 |
0.34 |
0.32 |
0.3 |
| EPS |
18.62 |
12.26 |
10.4 |
9.03 |
8.2 |
7.98 |
7.71 |
7.5 |
13.56 |
10.1 |
| EPS Diluted |
18.62 |
12.22 |
10.37 |
9 |
8.19 |
7.97 |
7.7 |
7.48 |
13.52 |
10.07 |
| Weighted Average Shares
Out |
$4.49 B
|
$4.53 B
|
$4.59 B
|
$4.67 B
|
$4.75 B
|
$4.84 B
|
$4.95 B
|
$5.06 B
|
$2.57 B
|
$2.62 B
|
| Weighted Average Shares
Out Diluted |
$4.49 B
|
$4.54 B
|
$4.61 B
|
$4.68 B
|
$4.76 B
|
$4.85 B
|
$4.96 B
|
$5.07 B
|
$2.58 B
|
$2.63 B
|
| Link |
|
|
|
|
|
|
|
|
|
|
